XXXX and outcomes.

@entity1 @entity8 @entity788 @entity260 @entity292 @entity1011 @entity715 @entity2548 @entity1211 @entity413 @entity165
OBJECTIVE: The objective of this study was to perform a retrospective analysis of the clinical evolution and surgical complications comparing @entity8 . METHODS: This review of 48 consecutive pancreas transplantation includes 39 simultaneous kidney and @entity8 (PAK) grafts as well as 2 retransplantations. @entity1211 was systemic (n = 29) or portal (n = 19). RESULTS: There were no significant differences in @entity1 , kidney, or pancreas allograft survival rates. There were no significant differences in levels of @entity1011 , fasting @entity413 , C-peptide, @entity165 , and homeostatic model assessment (HOMA) of beta cells, namely HOMA-s and HOMA-IR index. HbA1c was lower at 6 months and 1 year in the PE group (P < .05). Twenty-two @entity1 displayed @entity260 at a mean time of presentation of 12.8 days. All of these @entity1 but 2 needed relaparotomy. The other two were treated either conservatively (1 enteric @entity292 ) or by interventional radiology ( @entity2548 ). There were 10 graft losses, 5 in each group, due to @entity715 , @entity788 , and enteric fistulae. CONCLUSION: Early graft losses were related to @entity788 and @entity715 . Intermediate-term endocrine function was similar in both groups.
